Notably, EphA2-CAR-T cells were developed and tested on glioblastoma, where these cells recognized and suppressed EphA2-positive glioblastoma cells with significant reduction in in vivo tumor growth [126]. The gene discussed is EPHA2; the disease is glioblastoma.